期刊文献+

多发性骨髓瘤初发患者贫血相关的检验观察 被引量:4

下载PDF
导出
摘要 目的:研究血液红系参数和胱抑素C(cystatin C,CysC)的联合检测观察多发性骨髓瘤(multiple myeloma,MM)患者贫血病变程度的价值。方法:对56例MM初发住院患者进行相关实验室检查,根据血红蛋白(hemoglobin,HGB)水平分为3组:A组(HGB 43~75 g/L)18例,B组(HGB 76~98 g/L)19例,C组(HGB 101~146 g/L)19例。结果:3组之间的平均红细胞客积、平均血球血红蛋白、平均血球血红蛋白浓度各项目比较均无统计学意义(P>0.05)。A组、B组的红细胞分布宽度(red celldistribution width,RDW)、CysC均明显高于C组(P<0.001或P<0.01),A组和B组之间无明显差异(P>0.05);A组、B组的RDW、CysC阳性检出率明显高于C组(P<0.001或P<0.01),A组和B组之间也无明显差异(P>0.05)。56例患者的RDW、CysC分别与HGB呈明显负相关关系(r=-0.525,P<0.01;r=-0.553,P<0.01)。以C组为非明显贫血对照的ROC分析提示,RDW、CysC的曲线下面积(area under curve,AUC)分别为0.827、0.892,双因素下的AUC则可提高至0.946。结论:MM患者的明显贫血改变与RDW、CysC的升高有关,但在的贫血进程中升高不显著。血液指标RDW、CysC的检测能为研究MM患者相关贫血机制提供重要的临床依据。
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第1期110-112,共3页 Journal of Nanjing Medical University(Natural Sciences)
  • 相关文献

参考文献9

二级参考文献59

  • 1李娟.多发性骨髓瘤诊治新进展[J].实用医学杂志,2005,21(3):225-229. 被引量:15
  • 2王建文,彭佑铭,魏佳莉,刘伏友.多发性骨髓瘤44例肾损害临床特征分析[J].医学临床研究,2005,22(11):1537-1540. 被引量:9
  • 3孙艳虹,曾智杰,姜傥,高玲,罗美如,范敏珊.血清半胱氨酸蛋白酶抑制剂C在肾病患者肾功能评估中的应用[J].中华肾脏病杂志,2006,22(8):503-504. 被引量:35
  • 4邹剑峰(综述),侯健(审校).多发性骨髓瘤的肾损害的发病机制及防治进展[J].国际输血及血液学杂志,2007,30(4):323-327. 被引量:14
  • 5McCarthy HJ,Tizard EJ. Clinical practice:Diagnosis and management of Henoch-schonlein purpura [J]. Eur J Pediatr, 2010, 169(6) :643-650.
  • 6Qutb A,Syed G,Tamim HM,et al. Cystatin C-based formula is superior to MDRD, Cockcroft-Gauh and Nankivell formulae in estimating the glomerular filtration rate in renal allografts [ J ]. Exp Clin Transplant, 2009,7 (4) : 197 - 202.
  • 7Muto H,Ohashi K,Ando M,et al. Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation[J]. Int J Hematol,2010,91 (3):471- 477.
  • 8Song S, Meyer M, Turk TR, et al. Serum cystatin C in mouse models:a reliable and precise marker for renal function and superior to serum creatinine [J]. Nephrol Dial Transplant, 2009,24(4) : 1157-1161.
  • 9Eisenach JC,Thomas JA,Rauck RL,et al. Cystatin C in cerebrospinal fluid is not a disgnostic test for pain in humans[J]. Pain,2004,107(3) :207-212.
  • 10Massey D. Commentary:Clinical diagnostic use of cystatin C [J].J Clin Lab Anal, 2004, ! 8( 1 ) :55-60.

共引文献156

同被引文献36

  • 1罗泉芳,朱世为,廖东.白蛋白、C反应蛋白、乳酸脱氢酶对多发性骨髓瘤临床分期和预后的指导意义[J].实用老年医学,2013,27(5):396-398. 被引量:11
  • 2古爱虎,汪兴洪.多发性骨髓瘤治疗的现状和进展[J].中国骨肿瘤骨病,2006,5(3):175-179. 被引量:7
  • 3陆再英,钟南山.内科学[M].1版.北京:人民卫生出版社,2008,950.
  • 4Song MK,Chung JS,Seol YM,et al.Influence of low absolute lympho- cyte count of patients with nongerminal center center type diffuse large B -cell lymphoma with R-CHOP therapy[J].Ann Oncol,2010,21(1):140-144.
  • 5Dimopoulos MA,Terpos E,Chanan-Khan A,et al.Renal impairment in patients with multiple myeloma:a consensus statement on behalf of the international Myeloma Working Group[J].J Clin Oncol,2010,28(33):4976-4984.
  • 6Dimopoulos MA,Roussou M,Gavriatopoulou M,et al.Reversibility of renal impairment in patients with multiple treated with borte-zomib- based regimens:identification of predictive factors[J].Clin Lymphoma Myeloma,2009,9(4):302-306.
  • 7Murray ME,Gavile CM,Nair JR,et al.CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myelom[J].Blood,2014,123(24):3770-3779.
  • 8Feng P,Yan R,Dai X,et al.The alteration and clinical significance of th1/th2/th17/treg cells in patients with multiple myeloma[J].Inflammation,2014,15(1):467-474.
  • 9陈明霞,杨闯.血液分析对血液系统疾病筛查的意义[J].检验医学与临床,2008,5(4):215-216. 被引量:5
  • 10潘静,孙园园.多发性骨髓瘤患者血清胱抑素C水平的临床研究[J].临床荟萃,2010,25(3):233-234. 被引量:4

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部